|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 498/16 | (2006.01) |
| A61K 31/5365 | (2006.01) | ||
| A61K 47/48 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1651162 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04750945.0 |
| Date of filing the European patent application | 2004-05-20 | |
| (97) | Date of publication of the European application | 2006-05-03 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-21 |
| (46) | Date of publication of the claims translation | 2016-02-25 |
| (86) | Number | PCT/US2004/013314 |
| Date | 2004-05-20 |
| (87) | Number | WO 2004/103272 |
| Date | 2004-12-02 |
| (30) | Number | Date | Country code |
| 471739 P | 2003-05-20 | US |
| (72) |
WIDDISON, Wayne, C., US
CHARI, Ravi, V., J., US
|
| (73) |
ImmunoGen, Inc.,
830 Winter Street, Waltham, MA 02451,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Patobulinti citotoksiniai agentai, apimantys naujus maitanzinoidus |
| IMPROVED CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS |
| Payment date | Validity (years) | Amount | |
| 2023-05-02 | 347.00 EUR |